|
1
|
Tanaka M, Fernández-del Castillo C, Adsay
V, Chari S, Falconi M, Jang JY, Kimura W, Levy P, Pitman MB,
Schmidt CM, et al: International consensus guidelines 2012 for the
management of IPMN and MCN of the pancreas. Pancreatology.
12:183–197. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamaguchi K, Kanemitsu S, Hatori T,
Maguchi H, Shimizu Y, Tada M, Nakagohri T, Hanada K, Osanai M, Noda
Y, et al: Pancreatic ductal adenocarcinoma derived from IPMN and
pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas.
40:571–580. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Uehara H, Nakaizumi A, Ishikawa O, Iishi
H, Tatsumi K, Takakura R, Ishida T, Takano Y, Tanaka S and Takenaka
A: Development of ductal carcinoma of the pancreas during follow-up
of branch duct intraductal papillary mucinous neoplasm of the
pancreas. Gut. 57:1561–1565. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ingkakul T, Sadakari Y, Ienaga J, Satoh N,
Takahata S and Tanaka M: Predictors of the presence of concomitant
invasive ductal carcinoma in intraductal papillary mucinous
neoplasm of the pancreas. Ann Surg. 251:70–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanno S, Nakano Y, Sugiyama Y, Nakamura K,
Sasajima J, Koizumi K, Yamazaki M, Nishikawa T, Mizukami Y,
Yanagawa N, et al: Incidence of synchronous and metachronous
pancreatic carcinoma in 168 patients with branch duct intraductal
papillary mucinous neoplasm. Pancreatology. 10:173–178. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sugiyama M, Izumisato Y, Abe N, Masaki T,
Mori T and Atomi Y: Predictive factors for malignancy in
intraductal papillary-mucinous tumours of the pancreas. Br J Surg.
90:1244–1249. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Terris B, Ponsot P, Paye F, Hammel P,
Sauvanet A, Molas G, Bernades P, Belghiti J, Ruszniewski P and
Fléjou JF: Intraductal papillary mucinous tumors of the pancreas
confined to secondary ducts show less aggressive pathologic
features as compared with those involving the main pancreatic duct.
Am J Surg Pathol. 24:1372–1377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanno S, Nakano Y, Nishikawa T, Nakamura
K, Sasajima J, Minoguchi M, Mizukami Y, Yanagawa N, Fujii T, Obara
T, et al: Natural history of branch duct intraductal
papillary-mucinous neoplasms of the pancreas without mural nodules:
Long-term follow-up results. Gut. 57:339–343. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sawai Y, Yamao K, Bhatia V, Chiba T,
Mizuno N, Sawaki A, Takahashi K, Tajika M, Shimizu Y, Yatabe Y and
Yanagisawa A: Development of pancreatic cancers during long-term
follow-up of side-branch intraductal papillary mucinous neoplasms.
Endoscopy. 42:1077–1084. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohtsuka T, Kono H, Tanabe R, Nagayoshi Y,
Mori Y, Sadakari Y, Takahata S, Oda Y, Aishima S, Igarashi H, et
al: Follow-up study after resection of intraductal papillary
mucinous neoplasm of the pancreas; special references to the
multifocal lesions and development of ductal carcinoma in the
remnant pancreas. Am J Surg. 204:44–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yogi T, Hijioka S, Imaoka H, Mizuno N,
Hara K, Tajika M, Tanaka T, Ishihara M, Shimizu Y, Hosoda W, et al:
Risk factors for postoperative recurrence of intraductal papillary
mucinous neoplasms of the pancreas based on a long-term follow-up
study: Proposals for follow-up strategies. J Hepatobiliary Pancreat
Sci. 22:757–765. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hirono S, Kawai M, Okada K, Miyazawa M,
Shimizu A, Kitahata Y, Ueno M, Yanagisawa A and Yamaue H: Long-term
surveillance is necessary after operative resection for intraductal
papillary mucinous neoplasm of the pancreas. Surgery. 160:306–317.
2016. View Article : Google Scholar : PubMed/NCBI
|
